logo

For the Inventor, By the Inventor

Laguna Hills, CA, United States of America

Gary C Lee

USPTO Granted Patents = 21

Average Co-Inventor Count = 1.2

ph-index = 6

Forward Citations = 161(Granted Patents)


Location History:

  • Laguna Hille, CA (US) (1992)
  • Laguna Hills, CA (US) (1990 - 1994)

Company Filing History:

goldMedal21 out of 2,285 
 
Allergan, Inc.
 patents

Years Active: 1990-1994

Loading Chart...
21 patents (USPTO):Explore Patents
1. 5376676 - Process of using anti-inflammatory furanones as selective calcium (1994-12-27),
2. 5322953 - 2-trialkylsilyl-3-furaldehydes (1994-06-21),
3. 5298633 - Intermediates and processes for preparing 4-substituted 2-5(H)-furanones (1994-03-29),
4. 5225571 - Substituted dihydroxy-bis-[5-hydroxy-2(5H)-furanone-4-yl]-alkanes as (1993-07-06),
5. 5212172 - 4-(1-hydroxy-2-substituted amino)ethyl-5-hydroxy-2(5H)-furanones as (1993-05-18),
6. 5183906 - 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or (1993-02-02),
7. 5171864 - Di-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega alkane-dioates and (1992-12-15),
8. 5171863 - Intermediates for preparing 4-substituted 2-5(H)-furanones as (1992-12-15),
9. 5169963 - Di-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega alkanedioates (1992-12-08),
10. 5134128 - Anti-inflammatory furanones (1992-07-28),
11. 5089485 - Anti-inflammatory furanones (1992-02-18),
12. 5082954 - Intermediates and processes for preparing 4-substituted 2-5(H)-furanones (1992-01-21),
13. 5081261 - 4-(1-hydroxy-2-N-substituted sulfonamido) (1992-01-14),
14. 5081147 - 4-(1-hydroxy-2-substituted amino)ethyl-5-hydroxy-2(5H)-furanones as (1992-01-14),
15. 5059611 - Anti-inflammatory 5-hydroxy-2-furanones (1991-10-22),

Title: Innovations and Contributions of Gary C. Lee

Introduction

Gary C. Lee, a prominent innovator based in Laguna Hills, California, has made significant contributions to the field of pharmaceuticals with a portfolio of 21 patents to his name. His work focuses on the development of anti-inflammatory compounds, which hold potential for treating a wide array of health conditions.

Latest Patents

Among his latest innovations are patents related to the process of using anti-inflammatory furanones as selective calcium channel inhibitors. These compounds, specifically the 4-(C.sub.10 -C.sub.20)alkyl-2(5H)-furanone, offer therapeutic effects for various conditions such as hypertension, angina, cardiac arrhythmia, pulmonary hypertension, aortic insufficiency, Raynaud's disease, migraine headaches, and more. Furthermore, his research on 2-trialkylsilyl-3-furaldehydes explores the production of anti-inflammatory 4-substituted 2-furanones, utilizing intermediates that can significantly advance treatment options for diverse medical issues.

Career Highlights

Gary C. Lee's pioneering efforts have made substantial impacts in the pharmaceutical industry, especially through his work at Allergan, Inc. His expertise in drug development and innovation has been a driving force behind some of the latest advancements in anti-inflammatory therapies.

Collaborations

Throughout his career, Gary has collaborated with notable peers, including Michael E. Garst and John N. Bonfiglio. These partnerships have contributed to the research and development of groundbreaking therapies that address significant health challenges.

Conclusion

Gary C. Lee stands out as a key figure in pharmaceutical innovation, exemplifying dedication to discovering effective treatments for various diseases. His patents and collaborative efforts highlight the importance of innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…